NDC 0093-7865-19 - Fentanyl Citrate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0093-7865
- Requested NDC
- 0093-7865-19
- Package NDCs from labels
- 0093-7865-19, 0093-7865-65
- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- Effective date
- 2026-01-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Fentanyl Citrate - Teva Pharmaceuticals USA, Inc. | Teva Pharmaceuticals USA, Inc. | 2026-01-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0093-7865-19 | Fentanyl Citrate | 1 in 1 BLISTER PACK | LOZENGE | 1 | 16 | |
| 0093-7865-65 | Fentanyl Citrate | 30 in 1 CARTON | LOZENGE | 30 | 16 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0093-7865-19 | EA - Each | 0093-7865 | 167fb4ff-f7f3-4fa7-9cae-dca38b3602d3 | 1 | 2015-12-02 |
| 0093-7865-65 | EA - Each | 0093-7865 | 76aa8ab8-e9a9-4f34-960c-22261c534e1d | 1 | 2015-12-02 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE LOZENGE [TEVA PHARMACEUTICALS USA INC] | 1 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL CITRATE LOZENGE [TEVA PHARMACEUTICALS USA INC] | 1 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | FENTANYL CITRATE LOZENGE [TEVA PHARMACEUTICALS USA INC] | 1 | |
| DEXTRATES | INACTIVE INGREDIENT | G263MI44RU | FENTANYL CITRATE LOZENGE [TEVA PHARMACEUTICALS USA INC] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | FENTANYL CITRATE LOZENGE [TEVA PHARMACEUTICALS USA INC] | 1 | |
| MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE) | INACTIVE INGREDIENT | 461P5CJN6T | FENTANYL CITRATE LOZENGE [TEVA PHARMACEUTICALS USA INC] | 1 | |
| SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | 22ADO53M6F | FENTANYL CITRATE LOZENGE [TEVA PHARMACEUTICALS USA INC] | 1 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | FENTANYL CITRATE LOZENGE [TEVA PHARMACEUTICALS USA INC] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PHOSPHA 250 NEUTRAL | DIBASIC SODIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE AND MONOBASIC SODIUM PHOSPHATE | Rising Pharma Holdings, Inc. | 9432adfc-6add-4ab4-ae93-2e2daf348be2 | 2026-03-25 | Adverse reactions | 22ADO53M6F |
| Drop20 | FUCUS VESICULOSUS, CHELIDONIUM MAJUS, KALI PHOSPHORICUM, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, QUERCUS GLANDIUM SPIRITUS, QUERCUS ROBUR, NUX VOMICA, PHYTOLACCA DECANDRA, ORNITHOGALUM UMBELLATUM, AGNUS CASTUS, BERBERIS AQUIFOLIUM, BERBERIS VULGARIS, SACCHARUM OFFICINALE, SOLIDAGO VIRGAUREA, CALCAREA CARBONICA, CARBO VEGETABILIS, MAGNESIA PHOSPHORICA, NATRUM PHOSPHORICUM, SINAPIS ARVENSIS, FLOS, UBIDECARENONUM, GRAPHITES, HYPOPHYSIS SUIS, PLACENTA TOTALIS SUIS, HYPOTHALAMUS (BOVINE) | Pick Enterprises Corp | baa96813-dc95-472e-a834-880a0cd484a7 | 2026-03-13 | Warnings | C151H8M554 |
| Appetrol 20 | FUCUS VESICULOSUS, CHELIDONIUM MAJUS, KALI PHOSPHORICUM, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, QUERCUS GLANDIUM SPIRITUS, QUERCUS ROBUR, NUX VOMICA, PHYTOLACCA DECANDRA, ORNITHOGALUM UMBELLATUM, AGNUS CASTUS, BERBERIS AQUIFOLIUM, BERBERIS VULGARIS, SACCHARUM OFFICINALE, SOLIDAGO VIRGAUREA, CALCAREA CARBONICA, CARBO VEGETABILIS, MAGNESIA PHOSPHORICA, NATRUM PHOSPHORICUM, SINAPIS ARVENSIS, FLOS, UBIDECARENONUM, GRAPHITES, HYPOPHYSIS SUIS, PLACENTA TOTALIS SUIS, HYPOTHALAMUS (BOVINE) | Carbalor LLC | d66234a3-2477-42be-8f7b-283e3a5f87ed | 2026-03-12 | Warnings | C151H8M554 |
| Fentanyl Citrate | FENTANYL CITRATE | Hikma Pharmaceuticals USA Inc. | ce5db1c2-feb1-4ad2-847a-d02e865bd47e | 2026-03-06 | Boxed warning, Warnings, Adverse reactions | MUN5LYG46H |
| Kidnex IV | GINKGO BILOBA, ALPHA-KETOGLUTARICUM ACIDUM, CITRICUM ACIDUM, FUMARICUM ACIDUM, MALICUM ACIDUM, PYRUVIC ACID, SUCCINICUM ACIDUM, ARGENTUM METALLICUM, AURUM METALLICUM, CUPRUM METALLICUM, GERMANIUM SESQUIOXIDE, MERCURIUS VIVUS, NUX VOMICA, KIDNEY (SUIS), LYMPH NODE (SUIS), NAPHTHOCHINONUM, NATRUM OXALACETICUM, PHOSPHORUS, URINARY BLADDER (SUIS), ACONITICUM ACIDUM, CIS- | Energique, Inc. | 23de6b8e-7622-4ba6-89f7-37bd151687e2 | 2026-02-26 | Warnings | XF417D3PSL |
| Leader Extra Strength Effervescent Antacid and Pain Reliever | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Cardinal Health | c5d7bf5f-3e59-52f2-e053-2a95a90a4a00 | 2026-02-25 | Warnings | XF417D3PSL |
| Mitochondria Pro | ARALIA QUINQUEFOLIA, ARNICA MONTANA, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ALPHA-KETOGLUTARICUM ACIDUM, ASCORBICUM ACIDUM, ALPHA-LIPOICUM ACIDUM, CALCAREA CARBONICA, CITRICUM ACIDUM, CUPRUM METALLICUM, CYSTEINUM, FERRUM METALLICUM, IODIUM, LEVOTHYROXINUM, MAGNESIUM GLUCONICUM DIHYDRICUM, MALICUM ACIDUM, MANGANUM ACETICUM, NADIDUM, NATRUM PYRUVICUM, NICOTINAMIDUM, PYRIDOXINUM HYDROCHLORICUM, RIBOFLAVINUM, SELENIUM METALLICUM, SULPHUR, THIAMINUM HYDROCHLORICUM, UBIDECARENONUM, ZINCUM METALLICUM, | Energique, Inc. | 2f365207-b730-428d-9465-8853e86e79ff | 2026-02-18 | Warnings | XF417D3PSL |
| 4dbe9184-14cd-4666-aabf-1b7fece92337 | 78221eab-66fd-4cd8-9c81-af52eb83671c | 2026-01-31 | Boxed warning, Warnings, Adverse reactions | 4dbe9184-14cd-4666-aabf-1b7fece92337 78221eab-66fd-4cd8-9c81-af52eb83671c | ||
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | Atlantic Biologicals Corp. | 42d837ae-2578-46df-92d2-24774964aaad | 2026-01-28 | Adverse reactions | XF417D3PSL |
| Cell Energy Performance Drops 2048 | CELL ENERGY PERFORMANCE DROPS | Professional Complementary Health Formulas | 8701ea61-5d5f-466b-8d2c-f808e7b4d8fe | 2026-01-08 | Warnings | XF417D3PSL |
| Anti-Smoking II Drops 2008 | ANTI-SMOKING II DROPS | Professional Complementary Health Formulas | 8e64a0eb-4673-42e3-8387-7248d3855787 | 2026-01-08 | Warnings | C151H8M554 |
| Metab 6012 | METAB | Professional Complementary Health Formulas | f3576d6f-c9ab-4370-8a32-b6c4bf6ba4fd | 2026-01-08 | Warnings | XF417D3PSL |
| Substance Abuse Drops 2063 | SUBSTANCE ABUSE DROPS | Professional Complementary Health Formulas | 61f8263d-6f72-442f-a09e-57daf7226cc7 | 2026-01-08 | Warnings | C151H8M554 |
| Anti-Smoking I Drops 2007 | ANTI-SMOKING I DROPS | Professional Complementary Health Formulas | 1c6b5b98-971d-442a-b9eb-37f65409a521 | 2026-01-08 | Warnings | C151H8M554 |
| Glucose Drops 2031 | GLUCOSE DROPS | Professional Complementary Health Formulas | 21de3b86-be2b-4f71-9384-78ebc42ec087 | 2026-01-08 | Warnings | C151H8M554 |
| Herbal Diuretic Liquescence 3011 | HERBAL DIURETIC LIQUESCENCE | Professional Complementary Health Formulas | 5eee7f21-a3c4-46e0-a642-a4ca635734e3 | 2026-01-08 | Warnings | XF417D3PSL |
| Fentanyl Citrate | FENTANYL CITRATE | Civica, Inc. | aacf276b-e133-4199-ad3f-67b894744c04 | 2025-12-26 | Boxed warning, Warnings, Adverse reactions | MUN5LYG46H |
| Fentanyl Citrate | FENTANYL CITRATE | Phlow Corp. | 58dcd3f7-e3d8-4929-a186-8f680a51ff11 | 2025-12-23 | Boxed warning, Warnings, Adverse reactions | MUN5LYG46H |
| Fentanyl Citrate | FENTANYL CITRATE | Hikma Pharmaceuticals USA Inc. | c5fcdcbd-1dd1-4ebf-aa0d-edfe845414b7 | 2025-12-19 | Boxed warning, Warnings, Adverse reactions | MUN5LYG46H |
| HZ-Chord | BAPTISIA TINCTORIA, CEANOTHUS AMERICANUS, CITRICUM ACIDUM, ECHINACEA (ANGUSTIFOLIA), GELSEMIUM SEMPERVIRENS, HYDROCOTYLE ASIATICA, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, MEZEREUM, MORBILLINUM, NUX VOMICA, PALOONDO, PHYTOLACCA DECANDRA, SEPIA, THUJA OCCIDENTALIS, THYROIDINUM (BOVINE) | Energetix Corporation | 9685aec5-a65d-40fe-b5d7-2f13a69733bc | 2025-12-17 | Warnings | XF417D3PSL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.